|4Jan 26, 6:30 PM ET

Dickinson Klara 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 26, 2024

Insider Transaction Report

Form 4
Period: 2024-01-24
Dickinson Klara
SVP, Regulatory Affairs & QA
Transactions
  • Award

    Common Stock

    2024-01-24+21,00021,000 total
  • Award

    Employee Stock Option (right to buy)

    2024-01-24+78,00078,000 total
    Exercise: $22.85Exp: 2034-01-23Common Stock (78,000 underlying)
Footnotes (2)
  • [F1]The grant shall vest as to 1/4 of the shares on each of January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
  • [F2]The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES